Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
Saved in:
Main Authors: | Mathieu Roumiguie, Alberto Contreras-Sanz, Gunjan Kumar, Peter C. Black |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/4fb0060813c64bb1878148046dd05100 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reply to: Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
by: Ann Taber, et al.
Published: (2021) -
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
by: Ann Taber, et al.
Published: (2020) -
Cisplatin is retained in the cochlea indefinitely following chemotherapy
by: Andrew M. Breglio, et al.
Published: (2017) -
A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma
by: Qi Zhong, et al.
Published: (2018) -
Clinical Impact of Molecular Subtyping of Pancreatic Cancer
by: Zhou Xu, et al.
Published: (2021)